144 related articles for article (PubMed ID: 33878857)
1. The clinical course of COVID-19 in hematopoietic stem cell transplantation (HSCT) recipients.
Karataş A; Malkan ÜY; Velet M; Demiroğlu H; Büyükaşık Y; Telli Dizman G; Inkaya AÇ; Erdoğdu B; Çınar OE; Aladağ E; Aksu S; Haznedaroğlu İC; Özcebe O; Sayınalp N; Göker H
Turk J Med Sci; 2021 Aug; 51(4):1647-1652. PubMed ID: 33878857
[TBL] [Abstract][Full Text] [Related]
2. Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study.
Sharma A; Bhatt NS; St Martin A; Abid MB; Bloomquist J; Chemaly RF; Dandoy C; Gauthier J; Gowda L; Perales MA; Seropian S; Shaw BE; Tuschl EE; Zeidan AM; Riches ML; Shah GL
Lancet Haematol; 2021 Mar; 8(3):e185-e193. PubMed ID: 33482113
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 disease in children and adolescents following allogeneic hematopoietic stem cell transplantation: A report from the Turkish pediatric bone marrow transplantation study group.
Bozkurt C; Hazar V; Malbora B; Küpesiz A; Aygüneş U; Fışgın T; Karakükçü M; Kuşkonmaz B; Kılıç SÇ; Bayırlı D; Arman Bilir Ö; Yalçın K; Gözmen S; Uygun V; Elli M; Sarbay H; Küpesiz FT; Şaşmaz Hİ; Aksoy BA; Yılmaz E; Okur FV; Tekkeşin F; Yenigürbüz FD; Özek G; Atay AA; Bozkaya İO; Çelen S; Öztürkmen S; Güneş AM; Gürsel O; Güler E; Özcan A; Çetinkaya DU; Aydoğdu S; Özbek NY; Karasu G; Sezgin G; Doğru Ö; Albayrak D; Öztürk G; Aksoylar S; Daloğlu H; Odaman Al I; Evim MS; Akbayram S; Öncül Y; Zengin E; Albayrak C; Timur Ç; Kar YD; Çakmaklı HF; Tüfekçi Ö; Töret E; Antmen B
Pediatr Transplant; 2024 May; 28(3):e14758. PubMed ID: 38659218
[TBL] [Abstract][Full Text] [Related]
4. Impact of COVID-19 in hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
Shahzad M; Chaudhary SG; Zafar MU; Hassan MA; Hussain A; Ali F; Anwar I; Ahmed M; Ahmed N; Khurana S; Rauf MA; Anwar F; Hematti P; Callander NS; Abhyankar SH; McGuirk JP; Mushtaq MU
Transpl Infect Dis; 2022 Apr; 24(2):e13792. PubMed ID: 35030267
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 in hematopoietic stem-cell transplant recipients: A systematic review and meta-analysis of clinical characteristics and outcomes.
Randi BA; Higashino HR; Silva VPD; Xavier EM; Rocha V; Costa SF
Rev Med Virol; 2023 Nov; 33(6):e2483. PubMed ID: 37794598
[TBL] [Abstract][Full Text] [Related]
6. Outcome of SARS-CoV2 infection in hematopoietic stem cell transplant recipients for autoimmune diseases.
Greco R; Snowden JA; Knelange NS; Tridello G; Cacciatore C; Xhaard A; Ciceri F; Collin M; Ferra C; De Becker A; Badoglio M; Averbuch D; Alexander T; Ljungman P; De la Camara R;
J Autoimmun; 2023 Apr; 136():103024. PubMed ID: 37001437
[TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations and risk factors for COVID-19 and its severity in patients with hematological malignancies.
Wu TY; Tsai WT; Chen KH; Huang ST; Huang CF; Kuo PH; Tsai MJ; Liu WD; Lin KY; Huang YS; Cheng A; Chen PY; Sun HY; Huang HH; Huang TC; Wu SJ; Yao M; Wang JT; Sheng WH; Hung CC; Chen YC; Chang SC
J Microbiol Immunol Infect; 2024 Jun; 57(3):403-413. PubMed ID: 38480093
[TBL] [Abstract][Full Text] [Related]
8. Ursodeoxycholic acid does not reduce SARS-CoV-2 infection in newly allogeneic hematopoietic stem cell transplantation recipients: a prospective NICHE cohort.
Gao H; Wang J; Zheng X; Pei X; Zheng Y; Zhai W; Zhang R; Chen X; Ma Q; Wei J; Yang D; Pang A; He Y; Feng S; Cao Y; Jiang E
Front Cell Infect Microbiol; 2024; 14():1324019. PubMed ID: 38505288
[TBL] [Abstract][Full Text] [Related]
9. COVID-19 and hematopoietic stem cell transplantation and immune effector cell therapy: a US cancer center experience.
Maurer K; Saucier A; Kim HT; Acharya U; Mo CC; Porter J; Albert C; Cutler C; Antin JH; Koreth J; Gooptu M; Romee R; Wu CJ; Soiffer RJ; Nikiforow S; Jacobson C; Ho VT
Blood Adv; 2021 Feb; 5(3):861-871. PubMed ID: 33560397
[TBL] [Abstract][Full Text] [Related]
10. Covid-19 in liver transplant recipients: the French SOT COVID registry.
Dumortier J; Duvoux C; Roux O; Altieri M; Barraud H; Besch C; Caillard S; Coilly A; Conti F; Dharancy S; Durand F; Francoz C; Garaix F; Houssel-Debry P; Kounis I; Lassailly G; Laverdure N; Leroy V; Mallet M; Mazzola A; Meunier L; Radenne S; Richardet JP; Vanlemmens C; Hazzan M; Saliba F; ;
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101639. PubMed ID: 33636654
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics and outcomes of allogeneic hematopoietic stem cell transplantation recipients with coronavirus disease 2019 caused by the Omicron variant: a prospective, observational cohort study.
Fan S; Mo X; Zhang X; Xu L; Wang Y; Yan C; Chen H; Zhang Y; Cheng Y; Sun Y; Chen Y; Chen Y; Han W; Wang J; Wang F; Xu Z; Huang X
Ann Hematol; 2024 Apr; 103(4):1333-1344. PubMed ID: 38381172
[TBL] [Abstract][Full Text] [Related]
12. Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry.
Busca A; Salmanton-García J; Marchesi F; Farina F; Seval GC; Van Doesum J; De Jonge N; Bahr NC; Maertens J; Meletiadis J; Fracchiolla NS; Weinbergerová B; Verga L; Ráčil Z; Jiménez M; Glenthøj A; Blennow O; Tanase AD; Schönlein M; Prezioso L; Khanna N; Duarte RF; Žák P; Nucci M; Machado M; Kulasekararaj A; Espigado I; De Kort E; Ribera-Santa Susana JM; Marchetti M; Magliano G; Falces-Romero I; Ilhan O; Ammatuna E; Zompi S; Tsirigotis P; Antoniadou A; Zambrotta GPM; Nordlander A; Karlsson LK; Hanakova M; Dragonetti G; Cabirta A; Berg Venemyr C; Gräfe S; Van Praet J; Tragiannidis A; Petzer V; López-García A; Itri F; Groh A; Gavriilaki E; Dargenio M; Rahimli L; Cornely OA; Pagano L
Front Immunol; 2023; 14():1125030. PubMed ID: 36911708
[TBL] [Abstract][Full Text] [Related]
13. Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation.
Shah GL; DeWolf S; Lee YJ; Tamari R; Dahi PB; Lavery JA; Ruiz J; Devlin SM; Cho C; Peled JU; Politikos I; Scordo M; Babady NE; Jain T; Vardhana S; Daniyan A; Sauter CS; Barker JN; Giralt SA; Goss C; Maslak P; Hohl TM; Kamboj M; Ramanathan L; van den Brink MR; Papadopoulos E; Papanicolaou G; Perales MA
J Clin Invest; 2020 Dec; 130(12):6656-6667. PubMed ID: 32897885
[TBL] [Abstract][Full Text] [Related]
14. The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.
Webb BJ; Harrington R; Schwartz J; Kammerer J; Spalding J; Lee E; Dodds B; Kaufusi S; Goodman BE; Firth SD; Martin G; Sorensen J; Hoda D
Transpl Infect Dis; 2018 Oct; 20(5):e12961. PubMed ID: 29975816
[TBL] [Abstract][Full Text] [Related]
15. Intensive care unit support and Acute Physiology and Chronic Health Evaluation III performance in hematopoietic stem cell transplant recipients.
Afessa B; Tefferi A; Dunn WF; Litzow MR; Peters SG
Crit Care Med; 2003 Jun; 31(6):1715-21. PubMed ID: 12794410
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B virus among hematopoietic stem cell transplant recipients: Antiviral impact in seroconversion, engraftment, and mortality in a Latin American center.
Buzo BF; Ramos JF; Marques Rossetti RA; Salles N; Mendrone-Júnior A; Rocha V; de Seixas Santos Nastri AC
Transpl Infect Dis; 2020 Apr; 22(2):e13243. PubMed ID: 31901206
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 in hematopoietic stem cell transplant recipients during three years of the pandemic: a multicenter study in Brazil.
Randi BA; Higashino HR; Silva VPD; Salomão MC; Pignatari ACC; Abdala E; Vasques F; Silva CARD; Silva RLD; Lazari CDS; Levi JE; Xavier EM; Côrtes MF; Luna-Muschi A; Rocha V; Costa SF
Rev Inst Med Trop Sao Paulo; 2024; 66():e17. PubMed ID: 38511806
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 in HSCT recipients: a collaborative study of the Brazilian Society of Marrow Transplantation (SBTMO).
Daudt LE; Corso MCM; Kerbauy MN; de Assis LHDS; Rechenmacher C; Colturato I; Barbieri FR; Rocha V; Mariano L; Garcia JL; Dantas VECB; Loth G; Funke VAM; Pelegrina PRD; Duarte FB; da Silva RL; Araújo MAS; Carlesse FAMC; de Sousa AVL; Maia LA; Fernandes JF; Rodrigues CA; Bonfim C; Martins LNGF; Cipolotti R; Xavier EM; Gomes AA; Morales HMP; Simioni AJ; Soares VJ; Michalowski MB; Hamerschlak N; Machado CM
Bone Marrow Transplant; 2022 Mar; 57(3):453-459. PubMed ID: 35027676
[TBL] [Abstract][Full Text] [Related]
19. Characteristics comparisons of bacteremia in allogeneic and autologous hematopoietic stem cell-transplant recipients with levofloxacin prophylaxis and influence on resistant bacteria emergence.
Wang CH; Chang FY; Chao TY; Kao WY; Ho CL; Chen YC; Dai MS; Chang PY; Wu YY; Lin JC
J Microbiol Immunol Infect; 2018 Feb; 51(1):123-131. PubMed ID: 27103500
[TBL] [Abstract][Full Text] [Related]
20. Lessons learned from COVID-19 pandemic: outcomes after SARS-CoV-2 infection in hematopoietic cell transplant and cell therapy recipients.
Al-Ramahi JS; Shahzad M; Li K; DeJarnette S; Chaudhary SG; Lutfi F; Ahmed N; Balusu R; Bansal R; Abdelhakim H; Shune L; Singh AK; Abhyankar SH; McGuirk JP; Mushtaq MU
Leuk Lymphoma; 2023 Dec; 64(12):1981-1991. PubMed ID: 37574842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
